| Title |
Risperidone versus placebo for schizophrenia
|
|---|---|
| Published by |
John Wiley & Sons, Ltd, January 2010
|
| DOI | 10.1002/14651858.cd006918.pub2 |
| Pubmed ID | |
| Authors |
Rattehalli, Ranganath D, Jayaram, Mahesh B, Smith, Michael |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| India | 1 | 25% |
| United Kingdom | 1 | 25% |
| Unknown | 2 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 3% |
| Unknown | 32 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 8 | 24% |
| Student > Ph. D. Student | 6 | 18% |
| Student > Doctoral Student | 4 | 12% |
| Professor > Associate Professor | 4 | 12% |
| Student > Master | 3 | 9% |
| Other | 5 | 15% |
| Unknown | 3 | 9% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 48% |
| Psychology | 4 | 12% |
| Nursing and Health Professions | 3 | 9% |
| Social Sciences | 3 | 9% |
| Neuroscience | 2 | 6% |
| Other | 2 | 6% |
| Unknown | 3 | 9% |